Fujifilm to Seek Approval for Covid Drug After Trial Results

Fujifilm Holdings Corp. said it would seek regulatory approval in Japan to market an antiviral drug as a treatment for Covid-19, after a trial showed that it helped patients with mild cases test negative for coronavirus faster.